Durvalumab vs Rosuvastatin

Durvalumab vs Rosuvastatin: Overview

This comparison examines the pharmacological differences between Durvalumab and Rosuvastatin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Rosuvastatin — 19 hours.

Chemical Properties

Molecular Formula: Rosuvastatin — C22H28FN3O6S.

Molecular Weight: Rosuvastatin — 481.5390 g/mol.

Type: Durvalumab — Antibody; Rosuvastatin — Small molecule.